Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph K Han

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Allergy|December 18, 2023
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps carePeter W Hellings, Isam Alobid, Wilma T Anselmo-Lima, et al.
Lancet (London, England)|September 24, 2019
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsClaus Bachert, Joseph K Han, Martin Desrosiers, et al.
International Forum of Allergy & Rhinology|March 4, 2023
Nasal disease with polyps: Need for clarityRogerio Pezato, Aldo Cassol Stamm, Richard Douglas, et al.
International Forum of Allergy & Rhinology|February 19, 2016
International Consensus Statement on Allergy and Rhinology: RhinosinusitisRichard R Orlandi, Todd T Kingdom, Peter H Hwang, et al.
International Forum of Allergy & Rhinology|November 25, 2020
International consensus statement on allergy and rhinology: rhinosinusitis 2021Richard R Orlandi, Todd T Kingdom, Timothy L Smith, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Allergy|December 18, 2023
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps carePeter W Hellings, Isam Alobid, Wilma T Anselmo-Lima, et al.
Lancet (London, England)|September 24, 2019
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsClaus Bachert, Joseph K Han, Martin Desrosiers, et al.
International Forum of Allergy & Rhinology|March 4, 2023
Nasal disease with polyps: Need for clarityRogerio Pezato, Aldo Cassol Stamm, Richard Douglas, et al.
International Forum of Allergy & Rhinology|February 19, 2016
International Consensus Statement on Allergy and Rhinology: RhinosinusitisRichard R Orlandi, Todd T Kingdom, Peter H Hwang, et al.
International Forum of Allergy & Rhinology|November 25, 2020
International consensus statement on allergy and rhinology: rhinosinusitis 2021Richard R Orlandi, Todd T Kingdom, Timothy L Smith, et al.
Pageof 14